Clinical trial · Observational
Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.
Epidemiological Profile and Therapeutic Management of Patients Diagnosed With Cutaneous T-cell Lymphoma Evaluated in the Dermatology Department of Hospital México During the Period From 2019 to 2025.
NCT07538960CI-TRIAL-00108846not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Adult patients (≥18 years) with confirmed cutaneous T-cell lymphoma evaluated at Hospital México between 2019 and 2025 will be retrospectively analyzed using EDUS records to describe their epidemiological profile, clinical characteristics, treatments, and outcomes.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cutaneous | — | UNRESOLVED | — |
| Lymph Node Cancer | Malignant Lymph Node Neoplasm | ALIAS | 0.90 |
| T-cell Lymphoma | T-Cell Non-Hodgkin Lymphoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Characterize the epidemiology
- timeFrame
- 2019-2025
- description
- Characterize the epidemiology of patients diagnosed with cutaneous T-cell lymphoma evaluated in the Dermatology Service of Hospital México.
- measure
- Characterize the therapeutic management
- timeFrame
- 2019-2025.
- description
- Characterize the therapeutic management of patients diagnosed with cutaneous T-cell lymphoma evaluated in the Dermatology Service of Hospital México
Secondary outcomes (7)
- measure
- Describe the sociodemographic/epidemiological characteristics
- timeFrame
- 2019-2025
- description
- To describe the sociodemographic and epidemiological characteristics of patients diagnosed with cutaneous T-cell lymphoma evaluated in the Dermatology Service of Hospital México during the period from 2019 to 2025.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with a confirmed diagnosis of cutaneous T-cell lymphoma, established through clinical, histopathological, and immunohistochemical criteria, documented in EDUS of Hospital México in the Dermatology Service of Hospital México during the period between January 2019 and December 2025. * Patients aged 18 years or older, of both sexes. * Patients with at least one dermatological evaluation recorded during the study period. * Patients who, having a confirmed diagnosis, have received some modality of treatment, including skin-directed therapies (phototherapy, topical treatments, localized radiotherapy) and/or systemic treatments. Exclusion Criteria: * Clinical records that are insufficient or incomplete, preventing adequate diagnostic classification, staging, therapeutic characterization, or evaluation of clinical evolution. * Patients with a presumptive diagnosis of cutaneous T-cell lymphoma without histopathological confirmation. * Duplicate or inconsistent records that hinder the correct identification and classification of the patient. * Patients attended outside the established study period. * Patients outside the age range. * Patients who do not belong to the Dermatology Service of Hospital México.
References
Publications (0)
Data not yet available
No reference posted for this study.